Bruker (BRKR) Common Equity (2010 - 2026)

Bruker's Common Equity history runs 17 years deep, the most recent figure standing at $2.5 billion for Q1 2026.

• Quarterly Common Equity rose 34.6% year-over-year to $2.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 billion (up 34.6% YoY) and the FY2025 annual result came in at $2.5 billion, up 37.64% from the prior year.
• Common Equity was $2.5 billion for Q1 2026 at Bruker, roughly flat from $2.5 billion in the prior quarter.
• Across five years, Common Equity topped out at $2.5 billion in Q4 2025 and bottomed at $948.0 million in Q3 2022.
• A 5-year average of $1.6 billion and a median of $1.4 billion in 2024 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2022 — Common Equity dropped 13.0% — and 2024, when it surged 48.73%.
• Bruker's Common Equity stood at $1.1 billion in 2022, then climbed by 23.89% to $1.4 billion in 2023, then gained by 28.86% to $1.8 billion in 2024, then soared by 37.64% to $2.5 billion in 2025, then slipped by 0.26% to $2.5 billion in 2026.
• Business Quant data shows BRKR's Common Equity at $2.5 billion in Q1 2026, $2.5 billion in Q4 2025, and $2.4 billion in Q3 2025.